4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000038
Chief Legal Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Siegel Jolie · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Grant or award : show line 1 in the form | +20,000 | 25,097 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +90,000 | 90,000 | D |
Loading xslF345X03/wf-form4_167649753180992.xml…